Key In-app Coaching and Membership Features Showcase DarioHealth's Continued Ability to Disrupt the Digital Health Industry DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of its award-winning next-generation app,...
|
Earnings and Business Update Conference Call Scheduled for 9:00am EDT DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its first quarter 2018 results on Tuesday,...
|
Strengthens Marketing Team with Two New Executives to Build Business-to-Business Sales Force in the U.S. and to Expand Direct-to-Consumer Success Globally DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has hired U.S.-based digital health executive JC Muyl as...
|
Following U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter, DarioHealth Commences Pre-Orders for Existing Customers DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it will offer its past and current subscription holders the...
|
DarioHealth Bringing its Lightning®-enabled Version to the U.S. DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the United States Food and Drug Administration (FDA) has...
|
Record 4Q 2017 Revenue of $1.6 Million; growth of 88% DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the fourth quarter and...
|
Earnings and Business Update Conference Call Now Scheduled for 9:00am EDT on Monday, March 19, 2018 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that the previously announced earnings release and conference...
|
Earnings and Business Update Conference Call Scheduled for 9:00am EDT DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its fourth quarter and year end 2017...
|
DarioHealth Goes to Las Vegas to Share Vision on Shifting Diabetes Monitoring to a Focus on Personalization DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it is sharing its Dario Engage vision of moving diabetes...
|
Expansion onto Top eCommerce Retailer Platform Expands Accessibility of DarioHealth Products DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch and first sales of its Dario™ Blood Glucose...
|
Plans to Onboard the Clinic's 5,000 Patients as Dario Users DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has partnered with the Diabetes and Endocrinology Consultants of
|
The Dario™ Blood Glucose Monitoring System to Track Readings of Users in a Clinical Study by a Pharmaceutical Company DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has entered into an agreement with a pharmaceutical company...
|
Market Penetration "Down Under" Expected to Increase as Lightning® Enabled Version is Now Available DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has launched the Lightning®-enabled version of the...
|
Lightning® Enabled Version Affords Greater Market Penetration in Key Region DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced it has successfully sold the first Lightning®-enabled version...
|
|